Literature DB >> 29326028

A new era for treatment development in HER2-positive breast cancer.

Xavier Pivot1, David G Cox2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29326028     DOI: 10.1016/S1470-2045(18)30002-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Can we establish a hierarchy among trastuzumab biosimilar candidates?

Authors:  Xavier Pivot; Thierry Petit
Journal:  Br J Cancer       Date:  2018-07-13       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.